Drug Shortage Report for DEXAMETHASONE-OMEGA

Last updated on 2026-02-20

Report ID 272781
Drug Identification Number 02204266
Brand name DEXAMETHASONE-OMEGA
Common or Proper name Dexamethasone Sodium Phosphate Injection USP 4 mg/mL
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) DEXAMETHASONE PHOSPHATE
Strength(s) 4MG
Dosage form(s) LIQUID
Route of administration SOFT TISSUE INJECTION INTRAVENOUS INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR SOFT TISSUE INJECTION INTRAVENOUS INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR
Packaging size 5 x 5mL and 10 x 1mL vial / fiole
Anatomical Therapeutical Chemical (ATC) code H02AB
Anatomical Therapeutical Chemical (ATC) description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-11-26
Estimated end date 2026-03-31
Actual end date
Shortage status Actual shortage
Updated date 2026-02-20
Company comments The product is on allocation
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information [email protected] - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2026-02-20 French Compare
v14 2026-02-20 English Compare
v13 2026-02-20 French Compare
v12 2026-02-20 English Compare
v11 2026-02-20 French Compare
v10 2026-02-20 English Compare
v9 2026-01-06 French Compare
v8 2026-01-06 English Compare
v7 2025-12-30 French Compare
v6 2025-12-30 English Compare
v5 2025-12-22 French Compare
v4 2025-12-22 English Compare
v3 2025-11-27 French Compare
v2 2025-11-27 English Compare
v1 2025-11-27 English Compare

Showing 1 to 15 of 15